<qa>  What is the Phase 1 Study Evaluating the Safety of ABT-263 in CombinationThis is a Phase 1 Study Evaluating the Safety of ABT-263 in Combination with EtoposideCisplatin in Subjects with Small Cell Lung Cancer SCLC. 